Results 371 to 380 of about 626,622 (390)
Some of the next articles are maybe not open access.
Fibrinolysis in Venous Thromboembolism
Seminars in Thrombosis and Hemostasis, 2021AbstractFibrinolysis is of paramount importance in maintaining or regaining the patency of veins and pulmonary arteries obstructed by thrombi. Growing experimental and clinical evidence indicates that impaired fibrinolysis mediated by multiple complex mechanisms is involved in venous thromboembolism (VTE).
openaire +3 more sources
Anesthesia and Venous Thromboembolism
Obstetric Anesthesia Digest, 1986To the Editor.— The recent CONSENSUS CONFERENCE entitled "Prevention of Venous Thrombosis and Pulmonary Embolism" 1 is an admirable review of what is known concerning perioperative risk and management of a potentially life-threatening complication.
openaire +4 more sources
Hyperhomocysteinemia and Venous Thromboembolism
Seminars in Thrombosis and Hemostasis, 2006Homocysteine (Hcy) is a sulfhydryl amino acid derived from the metabolic conversion of methionine, which is dependent on vitamins (folic acid, B12 and B6) as cofactors or cosubstrates. Severe hyperhomocysteinemia (homocystinuria), due to inherited metabolic defects of Hcy metabolism, is associated with very high risk of venous thromboembolism (VTE ...
openaire +3 more sources
Venous thromboembolism and cancer
Blood Coagulation & Fibrinolysis, 1992The literature was reviewed in an attempt to determine whether patients with cancer have an increased risk of venous thromboembolism, i.e. deep vein thrombosis and pulmonary embolism. From case reports it was apparent that various thromboembolic or thrombophlebitic manifestations may be found in a small number of patients, although it is possible that ...
Rahr Hb, Sørensen Jv
openaire +3 more sources
Cancer and venous thromboembolism
The Lancet Oncology, 2005Venous thromboembolism occurs commonly in patients with cancer. The pathogenetic mechanisms of thrombosis involve a complex interaction between tumour cells, the haemostatic system, and characteristics of the patient. Among risk factors for thromboembolism are long-term immobilisation, especially in hospital, surgery, and chemotherapy with or without ...
PRANDONI, PAOLO, FALANGA A, PICCIOLI A.
openaire +3 more sources
Cancer-associated venous thromboembolism
Nature Reviews Disease Primers, 2022A. Khorana +7 more
semanticscholar +1 more source
Current Opinion in Cardiology, 1991
During the past year, the findings of several clinical trials have been published that have important implications for the care of patients with venous thromboembolism. These clinical trials have produced advances in the diagnosis and treatment of venous thrombosis and pulmonary embolism and in the prevention of venous thromboembolism in high-risk ...
Gary E. Raskob, Russell D. Hull
openaire +3 more sources
During the past year, the findings of several clinical trials have been published that have important implications for the care of patients with venous thromboembolism. These clinical trials have produced advances in the diagnosis and treatment of venous thrombosis and pulmonary embolism and in the prevention of venous thromboembolism in high-risk ...
Gary E. Raskob, Russell D. Hull
openaire +3 more sources
Preventing venous thromboembolism
Nursing Management, 2005Learn to recognize who's at risk for potentially fatal complications and how to reduce your patient's risks.
openaire +5 more sources
Treatment of Venous Thromboembolism
Cardiology in Review, 2002Venous thromboembolism (VTE), comprised of pulmonary embolism (PE) and deep vein thrombosis (DVT), is a disease entity with a significant morbidity and mortality. Anticoagulation, initially with intravenous heparin and followed with long term warfarin treatment is the traditional therapy for VTE.
And George P Maguire +2 more
openaire +3 more sources
Venous Thromboembolism Overview
Hematology/Oncology Clinics of North America, 2012This article gives a general overview of venous thromboembolism (VTE). Pathophysiology, presentation, diagnosis, and initial management of VTE are briefly reviewed. More difficult management problems are reviewed in greater depth, including duration of anticoagulation, treatment of superficial venous thrombosis, and controversies surrounding bridging ...
Jean M. Connors +2 more
openaire +3 more sources